Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Mesenchymal Stromal Cells in Bone Marrow Niche of Patients With Multiple Myeloma: A Double-Edged Sword Publisher



Kamrani S1 ; Naseramini R1 ; Khani P2 ; Razavi ZS3 ; Afkhami H4, 5, 6 ; Atashzar MR7 ; Nasri F8 ; Alavimanesh S9, 10 ; Saeidi F11 ; Ronaghi H1
Authors

Source: Cancer Cell International Published:2025


Abstract

Multiple myeloma (MM) is a hematological malignancy defined by the abnormal proliferation and accumulation of plasma cells (PC) within the bone marrow (BM). While multiple myeloma impacts the bone, it is not classified as a primary bone cancer. The bone marrow microenvironment significantly influences the progression of myeloma and its treatment response. Mesenchymal stromal cells (MSCs) in this environment engage with myeloma cells and other bone marrow components via direct contact and the secretion of soluble factors. This review examines the established roles of MSCs in multiple facets of MM pathology, encompassing their pro-inflammatory functions, contributions to tumor epigenetics, effects on immune checkpoint inhibitors (ICIs), influence on reprogramming, chemotherapy resistance, and senescence. This review investigates the role of MSCs in the development and progression of MM. © The Author(s) 2025.
Related Docs
View other Related Docs
1. Recent Advances in Mesenchymal Stem Cell Therapy for Multiple Sclerosis: Clinical Applications and Challenges, Frontiers in Cell and Developmental Biology (2025)
2. Therapeutic and Immunomodulatory Potentials of Mesenchymal Stromal/Stem Cells and Immune Checkpoints Related Molecules, Biomarker Research (2024)
3. Beyond Antibiotics: Mesenchymal Stem Cells and Bacteriophages-New Approaches to Combat Bacterial Resistance in Wound Infections, Molecular Biology Reports (2025)
Experts (# of related papers)
View all Related Experts
Samira Rajaei (1)
Naser Ahmadbeigi (1)
Other Related Docs
4. Various Signaling Pathways in Multiple Myeloma Cells and Effects of Treatment on These Pathways, Clinical Lymphoma# Myeloma and Leukemia (2018)
5. Signaling Crosstalk Between Mesenchymal Stem Cells and Tumor Cells: Implications for Tumor Suppression or Progression, Cytokine and Growth Factor Reviews (2024)
6. The Emerging Role of Exosomes in Multiple Myeloma, Blood Reviews (2019)
7. Biological Aspects and Clinical Applications of Mesenchymal Stem Cells: Key Features You Need to Be Aware Of, Current Pharmaceutical Biotechnology (2021)
8. Targeted Nano-Sized Drug Delivery to Heterogeneous Solid Tumor Microvasculatures: Implications for Immunoliposomes Exhibiting Bystander Killing Effect, Physics of Fluids (2023)
9. Mesenchymal Stem Cells in the Bone Marrow Microenvironment: A Double-Edged Sword for Aml, Journal of Cancer Research and Clinical Oncology (2025)
10. Mesenchymal Stem Cells (Mscs) and Msc-Derived Exosomes in Animal Models of Central Nervous System Diseases: Targeting the Nlrp3 Inflammasome, IUBMB Life (2023)
11. Current Knowledge on Therapeutic, Diagnostic, and Prognostics Applications of Exosomes in Multiple Myeloma: Opportunities and Challenges, Archives of Biochemistry and Biophysics (2024)
12. A Comprehensive Review of the Pten/Pi3k/Akt Axis in Multiple Myeloma: From Molecular Interactions to Potential Therapeutic Targets, Pathology Research and Practice (2024)
13. The Effect of Mesenchymal Stem Cell-Conditioned Medium on Proliferation and Apoptosis of Breast Cancer Cell Line, Journal of Cancer Research and Therapeutics (2018)
14. The Clinical Trials of Mesenchymal Stromal Cells Therapy, Stem Cells International (2021)
15. Valproic Acid Inhibits the Protective Effects of Stromal Cells Against Chemotherapy in Breast Cancer: Insights From Proteomics and Systems Biology, Journal of Cellular Biochemistry (2018)
16. Challenges in Mesenchymal Stromal Cell-Based Therapies, Current Stem Cell Research and Therapy (2023)
17. Mesenchymal Stem Cell-Based Scaffolds in Regenerative Medicine of Dental Diseases, Stem Cell Reviews and Reports (2024)
18. Cancer-Associated Mesenchymal Stem/Stromal Cells: Role in Progression and Potential Targets for Therapeutic Approaches, Frontiers in Immunology (2023)
19. Recruited Bone Marrow Derived Cells, Local Stromal Cells and Il-17 at the Front Line of Resistance Development to Anti-Vegf Targeted Therapies, Life Sciences (2019)
20. Bone Marrow Microenvironment in Myelodysplastic Neoplasms: Insights Into Pathogenesis, Biomarkers, and Therapeutic Targets, Cancer Cell International (2025)